Can Medication Help with Orthostatic Hypotension?

Published: Apr 15, 2024

For those struggling with orthostatic hypotension, medications can offer relief when lifestyle changes aren't enough. Discover which medications might work for you.

Fludrocortisone: Volume Booster

Fludrocortisone is a medication that helps your body retain salt and water, which increases your blood volume and pressure. It's often used when increasing salt and water intake isn't enough. Though effective, it can have side effects like swelling and high blood pressure when lying down, so it's important to use it under medical supervision.

Midodrine: Raising Resistance

Midodrine works by tightening blood vessels, which increases blood pressure. It's especially helpful for people whose symptoms don't improve with salt and water alone. However, it should not be taken close to bedtime, as it can cause high blood pressure when lying down. Common side effects include goosebumps, itching, and stomach discomfort.

Orthostatic hypotension is a form of low blood pressure that happens when you stand up from sitting or lying down, leading to dizziness or lightheadedness.

Droxidopa: A Modern Solution

Droxidopa is a newer medication that helps your body produce norepinephrine, a chemical that raises blood pressure. It's particularly useful for patients with neurological issues. The dosage can vary, and it's essential to monitor blood pressure regularly to avoid potential side effects like headaches and nausea.

Frequently Asked Questions

It helps retain salt and water to increase blood volume and pressure.

It tightens blood vessels to raise blood pressure.

Yes, it's effective, especially for those with neurological conditions.

Yes, side effects can include headaches, nausea, and high blood pressure when lying down.

Key Takeaways

Medications can be effective but should be used with caution and regular monitoring.

Discuss with Doctronic to see which medication might be right for you.

Related Articles

References

Isaacson S, Shill HA, Vernino S, et al. Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303). J Parkinsons Dis 2016; 6:751.

Hauser RA, Hewitt LA, Isaacson S. Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A). J Parkinsons Dis 2014; 4:57.

Always discuss health information with your healthcare provider.